Incredible, a while back, We estimate ENUM's 12-month price target of $4.50 per share yielding a market cap of approximately $235 million. The company is not without risks such as failure to develop its internal programs and failure to acquire corporate partners. However, we believe that Enumeral has strong potential with a favorable risk/reward profile for investors with a relatively long investment strategy.
Everything I say is in my opinion, do your own DD and make your decision wisely! Don't spend more then you can afford to lose!